First-Cousin Couple Requesting 'Testing for Everything'
A 29-year-old woman at 10 weeks' gestation presents with her 31-year-old husband; they are first cousins and both grew up in a community with frequent cousin marriage. Neither has a known genetic condition, and their 2-year-old daughter is healthy. They request 'a test that checks the baby for all genetic diseases' because a cousin's child was diagnosed with spinal muscular atrophy at 8 months. The couple is unsure about termination and says they 'just want to know.' The counselor has access to a carrier screening panel of 180 genes, including SMN1, CFTR, and HBB, and can offer prenatal diagnosis after carrier results. The patient has low hemoglobin and mild anemia; her husband has no anemia.
1. What carrier screening strategy and consent discussion are appropriate?
Read the worked answer
Start with the family history and clarify which cousin's child has SMA and how that person is related to each partner; this affects the prior probability and whether the couple may be at risk for the same condition. Consanguinity increases the chance that both partners carry the same autosomal recessive variant, but it does not make a 180-gene panel exhaustive. Offer carrier screening to both partners, ideally before pregnancy or as soon as possible, and explain that a panel detects common variants but not all pathogenic variants, so a negative result reduces but does not eliminate risk. Discuss the possibility of variants of uncertain significance and the need for separate consent for each partner. Address the patient's anemia: low hemoglobin may reflect iron deficiency, thalassemia trait, or another condition, and HBB and HBA screening may be relevant. Explain that 'testing for everything' is not possible and that the goal is risk reduction, not a guarantee. Document consent and the limits of the panel.
2. The patient is an SMA carrier and her husband's SMN1 result is negative. What should the counselor explain?
Read the worked answer
Explain that SMA is autosomal recessive and that the husband's negative SMN1 result substantially reduces, but does not eliminate, the chance that the fetus is affected. Standard carrier testing may miss some variants, especially when copy-number analysis is used without full sequencing, and rare de novo or non-allelic situations exist. If the husband's testing was copy-number only, consider whether reflex sequencing or a second method is available, and clarify the residual risk. The couple's prior risk before results was low but not zero because of consanguinity; now it is much lower for SMA, but other recessive conditions remain possible because they share ancestry. Offer continued carrier screening for other conditions, including CFTR and HBB, and explain that prenatal diagnosis for SMA is not indicated on the basis of one carrier result alone. Discuss that the cousin's child's diagnosis does not mean this couple has the same variants. Reassure without overpromising and document the residual-risk discussion.
3. How should the counselor address the request to test 'the baby for all diseases' and the couple's uncertainty about termination?
Read the worked answer
Correct the expectation gently: no prenatal test can detect all genetic diseases, and broad sequencing can produce uncertain results, incidental findings, and anxiety without improving care. Explain the difference between carrier screening, prenatal diagnostic testing with karyotype or microarray, and exome sequencing, which is usually reserved for fetuses with anomalies. Ask what they would do with each type of result and explore their views on termination, parenting a child with a disability, and family pressure. Because they are unsure, avoid scheduling diagnostic testing until they have decided what information they want. Offer genetic counseling over time, written decision aids, and a follow-up visit after carrier results. If they choose prenatal diagnosis later, confirm informed consent and discuss the range of possible results. Respect their reproductive autonomy and do not steer them toward testing or termination. Document their values and the options presented.